Hormonal contraception injections for women have been around for decades. Unfortunately, recent studies have found a potential link between medroxyprogesterone acetate, a common type of hormonal contraception taken through injection, and intracranial meningioma, a type of brain tumor. Many women who have used this form of birth control for extended periods have also suffered from intracranial meningioma. The goal of this blog post is to examine the potential association between medroxyprogesterone acetate (Depo-Provera) and brain tumors and the current status of litigation alleging this connection.
What Is Medroxyprogesterone Acetate (MPA)?
MPA is the technical name for an injectable form of hormonal contraception for women. If you or your partner used contraception, you might not have ever heard of medroxyprogesterone acetate or MPA, but you probably heard of the brand name, Depo-Provera.